Cargando…
Cost effectiveness and budget impact of universal varicella vaccination in Russia
This economic evaluation assesses the cost-effectiveness and budget impact of introducing a two-dose varicella vaccine in the Russian national immunization program. A static Markov model followed a simulated 2019 Russian cohort over its lifetime and compared outcomes and costs of three varicella vac...
Autores principales: | Marijam, Alen, Safonova, Ekaterina, Scherbakov, Mikhail, Shpeer, Evgeniy, Van Oorschot, Desirée, Rudakova, Alla, Tatochenko, Vladimir, Briko, Nikolay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196720/ https://www.ncbi.nlm.nih.gov/pubmed/35258445 http://dx.doi.org/10.1080/21645515.2022.2045152 |
Ejemplares similares
-
A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children
por: Namazova-Baranova, Leyla, et al.
Publicado: (2021) -
Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus
por: Hwang, Ji-Young, et al.
Publicado: (2023) -
Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study
por: Zhang, Zhuoyu, et al.
Publicado: (2023) -
Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
por: Sun, Dapeng, et al.
Publicado: (2023) -
Seroprevalence comparison of different varicella vaccines among Turkish children
por: Choi, BongKyoo, et al.
Publicado: (2022)